Delivery Order SPE2DB22D2211-SPE2DB24FMSP0
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $7.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,530.62 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corporation's Corporate Office Division a $7,256.75 firm-fixed-price delivery order contract for the pharmaceutical product OZEMPIC 1MG/0.75ML. This order was placed under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to DLA facilities...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $33,560.98, is for the provision of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, with a potential value of $1,741.62, is for the delivery of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is valued at $11,533.00 and has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp will provide the DLA with the pharmaceutical product OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,780.11 to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML and has an ultimate completion date of March 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $7,327.60 to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract and there is no set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a potential value of $5,805.40 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $5,805.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides a wide range of pharmaceutical products and medical...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMSP0Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation. The $7,213.29 award is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not utilize any set-aside designations.
Generated 5/1/24, 10:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 1/31/24 |